Scailteux, Lucie-Marie <br/><br/>
Use of 5α-reductase inhibitors for benign prostate hypertrophy and risk of high grade prostate cancer: a French population-based study.  [electronic resource] 

 -  BJU international  02 2019 
 - 293-299 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1464-410X 
<br/><br/><label>Standard No.: </label>10.1111/bju.14495  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>5-alpha Reductase Inhibitors--therapeutic use<br/>Aged<br/>Aged, 80 and over<br/>Case-Control Studies<br/>Databases, Factual<br/>France<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Grading<br/>Prostatic Hyperplasia--drug therapy<br/>Prostatic Neoplasms--pathology<br/>Risk Factors<br/>Time Factors